| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2026 ( Subtotal = $68,218,405 ) (Continued on the next page) |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R37AI131771 | Statistical methods and designs for correlated outcome and covariate errors in studies of HIV/AIDS | 001 | 9 | NIH | 2/16/2026 | $8,774 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI180038 | Human M Cells Require Coronin 1a | 000 | 3 | NIH | 12/31/2025 | $706,382 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI172064 | Regional Prospective Observational Research in Tuberculosis (RePORT) – Brazil Network | 000 | 4 | NIH | 1/9/2026 | $527,252 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012468 | Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program | 002 | 4 | NIH | 2/20/2026 | $55,859 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U01AI172064 | Regional Prospective Observational Research in Tuberculosis (RePORT) – Brazil Network | 001 | 4 | NIH | 1/13/2026 | $472,748 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 001 | 3 | NIH | 1/12/2026 | $93,723 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG084550 | Systematically screening and validating drug repurposing candidates for Alzheimer's Disease and Related Dementias | 000 | 2 | NIH | 1/13/2026 | $766,423 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI093234 | Statistical Methods for Ordinal Variables in HIV/AIDS Studies | 000 | 12 | NIH | 1/7/2026 | $580,364 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08AI185260 | A Translational Bioinformatics Approach for Phenotyping and Genetic Risk of Severe Cutaneous Adverse Drug Reactions | 000 | 2 | NIH | 12/31/2025 | $186,332 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08EY032620 | Mechanisms of Photoreceptor Contribution to Retinal Inflammation in Diabetic Retinopathy | 000 | 5 | NIH | 1/9/2026 | $207,847 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $17,925 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $56,277 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R25TW012715 | Vanderbilt-Nigeria Research Ethics Training Program (V-NET) | 000 | 3 | NIH | 12/25/2025 | $80,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK133512 | Hepatic stellate cells in liver homeostasis and regeneration | 000 | 3 | NIH | 12/29/2025 | $616,459 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG092663 | Probing mechanistic links between endothelial aging and dementia | 001 | 1 | NIH | 1/9/2026 | $0 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01NS141191 | Cerebrospinal fluid dynamics in Huntington's disease | 000 | 2 | NIH | 1/14/2026 | $558,967 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK131070 | The Origins of Human Anti-Insulin B Lymphocytes in Type 1 Diabetes | 000 | 5 | NIH | 1/15/2026 | $421,441 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AG092663 | Probing mechanistic links between endothelial aging and dementia | 000 | 1 | NIH | 12/30/2025 | $734,957 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K25AG076864 | Development and Application of T1rho Dispersion Imaging of Aging Muscle | 000 | 4 | NIH | 1/15/2026 | $75,600 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK132669 | Arginine regulation of alpha cell proliferation and function | 000 | 5 | NIH | 1/16/2026 | $412,210 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK131529 | Pathophysiology of Metabolically Detrimental Changes in Adipose Distribution, Adipocyte Function, and Adipose Immune Environment on Antiretroviral Therapy | 000 | 5 | NIH | 1/16/2026 | $856,050 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | U24TR004432 | Catalyzing and Harmonizing Operational Innovation for Recruitment (CHOIR) | 003 | 3 | NIH | 1/16/2026 | $326,759 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK135950 | in vivo MR characterization of pathological changes in liver microstructures | 000 | 3 | NIH | 1/16/2026 | $387,557 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | NUR3DD000107 | Tennessee ADDM: Enhancing Public Health Surveillance of Autism Spectrum Disorder through the Autism and Developmental Disabilities Monitoring (ADDM) Network | 00 | 4 | CDC | 1/5/2026 | $450,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012468 | Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program | 001 | 4 | NIH | 2/20/2026 | $87,762 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI187244 | Care, Review, Assessment and Feedback Tool In Acute Respiratory infections (CRAFT-IAR) | 000 | 2 | NIH | 2/21/2026 | $858,071 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AI176521 | Characterizing antibody responses to HIV-1 vaccination in next-generation immune humanized mice | 000 | 4 | NIH | 1/26/2026 | $400,175 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UL1TR002243 | Vanderbilt Institute for Clinical and Translational Research (VICTR) | 000 | 10 | NIH | 3/4/2026 | $10,899,283 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R37CA263614 | TCR signaling and cell cycle regulation in tumor-specific CD8 T cell dysfunction | 000 | 5 | NIH | 3/5/2026 | $556,308 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012750 | Vanderbilt-Mozambique Biomedical Informatics (VM-BMI) Training and Research Program | 000 | 3 | NIH | 12/18/2025 | $181,255 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UG3HG014374 | Genetic variant Evidence using Novel tools to Elucidate Pathophysiology: Accelerating Translation to Health (GenePath) | 000 | 1 | NIH | 2/16/2026 | $500,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UG3HG014374 | Genetic variant Evidence using Novel tools to Elucidate Pathophysiology: Accelerating Translation to Health (GenePath) | 000 | 1 | NIH | 2/16/2026 | $693,092 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012468 | Peru Vanderbilt – PREvention through VacciNation Training (PREVENT) program | 000 | 4 | NIH | 2/17/2026 | $103,090 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK134692 | Commensal bacteria resilience mechanisms in the inflamed intestine | 000 | 4 | NIH | 2/18/2026 | $345,728 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01MH132022 | Next generation transcranial ultrasound-based neuromodulation using phase shift nanoemulsions | 000 | 4 | NIH | 2/10/2026 | $765,144 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL161095 | Hemodynamic Effects of Positive Airway Pressure to Treat Supine Hypertension and Improve Neurogenic Orthostatic Hypotension | 000 | 5 | NIH | 2/12/2026 | $558,202 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012268 | Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat) | 001 | 5 | NIH | 2/9/2026 | $87,561 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K08DA058046 | Measuring and modifying delay discounting as a mechanism of smoking in pregnancy | 000 | 3 | NIH | 2/10/2026 | $185,304 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R35GM156389 | Structure and function of phospholipids and inositol phosphates in the nucleus. | 000 | 2 | NIH | 2/18/2026 | $656,250 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | UM1AI069439 | Vanderbilt HIV Clinical Trials Unit (CTU) | 000 | 21 | NIH | 12/9/2025 | $1,385,340 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23DA057387 | Low-dose buccal buprenorphine: Relative abuse potential and postoperative analgesic acceptability | 000 | 4 | NIH | 2/19/2026 | $172,795 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K23DA059690 | Network-Targeted Neuromodulation for Nicotine Dependence in Schizophrenia | 000 | 3 | NIH | 2/10/2026 | $185,544 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01HL164526 | Circulating Proteomics to Phenotype the Development and Reversal of Myocardial Remodeling in Aortic Stenosis | 000 | 4 | NIH | 2/13/2026 | $746,098 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01DK141801 | Liver and kidney responses to bilirubin as a nuclear receptor hormone | 000 | 2 | NIH | 12/10/2025 | $380,625 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01CA289528 | Molecular Mediators of Cell-free DNA biogenesis | 000 | 2 | NIH | 12/11/2025 | $603,132 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | R01AR080629 | Predicting risk of systemic autoimmune disease in patients with positive antinuclear antibodies | 001 | 5 | NIH | 2/9/2026 | $372,447 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012268 | Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat) | 000 | 5 | NIH | 2/2/2026 | $160,132 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | D43TW012268 | Vanderbilt-Nigeria Biostatistics Training Program (VN-BioStat) | 000 | 5 | NIH | 2/2/2026 | $50,000 |
| | 2026 | 2026 | VANDERBILT UNIVERSITY MEDICAL CENTER | 1161 21ST AVE S STE D3300 MCN | NASHVILLE | TN | 37232-0001 | DAVIDSON | USA | K00AG079810 | Longitudinal effects of aging and neurodegeneration on structure-function and brain-behavior relationships | 000 | 4 | NIH | 2/13/2026 | $80,892 |
|
